Tag: Brainomix 360 Stroke
Brainomix announces multiple study presentations highlighting clinical impact of 360 Stroke...
Brainomix has announced the recent presentation of a series of studies at the European Stroke Organisation Conference (ESOC; 21–23 May, Helsinki, Finland), providing new...
Brainomix gains US FDA clearance for new core volume assessment feature
Brainomix has announced the US Food and Drug Administration (FDA) clearance of a novel and patented feature that enables physicians to assess ischaemic core...
Brainomix completes £14 million Series C funding round
Brainomix recently announced the completion of a £14 million (US$18 million) Series C investment round co-led by prominent health technology investors, including existing investors...
New data presented at ISC 2025 further validate treatment impact of...
Brainomix will be unveiling a series of new studies this week at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), further validating...
Brainomix announces presentation of US data validating AI technology in stroke...
Brainomix has announced new data from studies that were presented this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
Brainomix announces increased thrombectomy rates at UK centres using its AI...
Brainomix has announced that results from what it claims is the largest prospective study of stroke artificial intelligence (AI) software were presented yesterday at...
